Hydrochloric Acid → HCID 67071612, compound
Reaction equation
B.[CH:2]([O:5][C:6]1[N:11]=[CH:10][C:9]([O:12][C:13]2[CH:18]=[CH:17][C:16]([CH2:19][CH2:20][C@H:21]([NH2:25])[CH:22]([CH3:24])[CH3:23])=[CH:15][CH:14]=2)=[CH:8][CH:7]=1)([CH3:4])[CH3:3].C1COCC1.C(ON=C(C(C)C)CCC1C=CC(OC2C=NC(OC(C)C)=CC=2)=CC=1)C1C=CC=CC=1.O1CCOB1OC(C1C=CC=CC=1)(C1C=CC=CC=1)[C@@H](N)C(C)C.B.C1COCC1.Cl.[OH-].[Na+]>C1COCC1>[CH:2]([O:5][C:6]1[N:11]=[CH:10][C:9]([O:12][C:13]2[CH:18]=[CH:17][C:16]([CH2:19][CH2:20][C@@H:21]([NH2:25])[CH:22]([CH3:24])[CH3:23])=[CH:15][CH:14]=2)=[CH:8][CH:7]=1)([CH3:4])[CH3:3]Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 1
Procedure
(S)-1-{2-[4-(6-isopropoxypyridin-3-yloxy)phenyl]ethyl}-2-methylpropylamine Borane-THF (2.87 ml, 2.87 mmol) is added dropwise under argon at 0° C. to 1-[4-(6-isopropoxypyridin-3-yloxy)phenyl]-4-methylpentan-3-one O-benzyloxime (310 mg, 0.717 mmol) in 15 ml of anhydrous THF. Then, (S)-1-[([1,3,2]dioxaborolan-2-yloxy)-diphenylmethyl]-2-methylpropylamine (23.3 mg) is added and the mixture is stirred for 2 days. Following addition of twice 1.5 ml of borane-THF stirring is continued for 4 h each time. % N hydrochloric acid is carefully added for hydrolysis, the mixture is rendered alkaline with aqueous sodium hydroxide solution and extracted with ethyl acetate. The organic phase is separated off, concentrated and purified by preparative HPLC (PR18, acetonitrile/water 0.1% TFA). Yield: 160 mg (68%), M+H+: 329.3. Chiral chromatography is performed (Chiralcel OD-H, heptane:ethanol=5:1+0.1% DEA) to obtain the enantiomers (R)-1-{2-[4-(6-isopropoxypyridin-3-yloxy)phenyl]ethyl}-2-methylpropylamine (RF: 4.442 min), Yield: 49 mg (21%), M+H+: 329.3. (S)-1-{2-[4-(6-Isopropoxypyridin-3-yloxy)phenyl]ethyl}-2-methylpropylamine (RF: 5.965 min), Yield: 50 mg (21%), M+H+: 329.3.
Workup
- waitis continued for 4 h
- extractionextracted with ethyl acetate
- customThe organic phase is separated off
- concentrationconcentrated
- custompurified by preparative HPLC (PR18, acetonitrile/water 0.1% TFA)
Sources & evidence
- ORD record
- ord-96c6a3a28b294cabaff25d835c8740fa
- Source dataset
- uspto-grants-2013_06
- Patent number
- US08470841B2
Reaction notes
Loading…